Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Neuropsychiatric symptoms are common in Parkinson's disease (PD) and have a disproportionate impact on quality of life and carer burden. Pharmacological treatment is the main approach in dealing with these symptoms, but it is limited by variable efficacy and risk of drug interactions. Non-pharmacological approaches using the cognitive–behavioural therapy (CBT) model are viable alternatives and in this review paper we summarise the evidence of CBT for three of the most common psychiatric manifestations of PD: depression and anxiety, impulse-control disorders and insomnia. Most studies modified the usual CBT format to include modules accounting for problems specific to PD: activity scheduling around motoric function, motor symptoms as triggers of anxiety, fear of falling and preparation for disease progression as well as accommodation of materials for suspected executive dysfunction. We found a growing evidence base that CBT (modified to account for PD-specific problems) is effective in the treatment of PD psychiatric symptoms. Where controlled study design was used, moderate effect sizes are reported for the efficacy of CBT for depression, including with distance administration of CBT. The effects were sustained during follow-up which was between 1 and 6 months. In addition, there are some initial data on the effects of CBT on impulse-control disorders and insomnia. The studies were limited by their small and potentially unrepresentative samples and the quality of sample reporting (eg, concomitant antidepressant and dopaminergic therapy use). Additional well-designed and adequately powered studies are required to determine the utility of CBT in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.1184 · Cited by 2,948
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050 · cited 1×
“Depression and anxiety are the strongest predictors of poorer quality of life,(5) even in the advanced stages of the illness where the motor features have progressed fully.(6) ICD are characterised by repetitive, reward-based behaviours, linked to the dopaminergic medication used to treat the motor symptoms.”
BackgroundBehavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial
Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., et al. (2010) · JAMA · doi:10.1001/jama.2010.607 · Cited by 790
Simpson, H. B., Foa, E. B., Liebowitz, M. R., Ledley, D. R., Huppert, J. D., Cahill, S., Vermes, D., Schmidt, A. B., Hembree, E., Franklin, M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091440 · Cited by 316 · cited 1×
“CBT has a broad evidence base in the treatment of psychiatric disorders in the general population – depression and anxiety [19], obsessive-compulsive [20], eating [21] and Tourette’s”
BackgroundCognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., Bienfait, K. L., & Friedman, J. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111669 · Cited by 310 · cited 4×
“Depression and anxiety (distance CBT) Dobkin et al (2011)36 21 PD Primary outcome: HAM-D Uncontrolled telephone CBT plus caregiver educational sessions Duration: 10 weeks; follow-up: 4 weeks Age 65.9±9.4 Disease duration 7.5 ±9.4 Significant improvement in depression with 62% meeting criteria for…”
BackgroundMethodInfluentialMohr, D. C., Likosky, W., Bertagnolli, A., Goodkin, D. E., Van Der Wende, J., Dwyer, P., & Dick, L. P. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.2.356 · Cited by 240 · cited 1×
“Importantly, CBT has also been shown to be efficacious in the treatment of anxiety and depression in the context of chronic neurological [23] and other physically disabling conditions [24].”
BackgroundMohr, D. C., Vella, L., Hart, S., Heckman, T., & Simon, G. (2008) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.2008.00134.x · Cited by 227 · cited 1×
“Remotely administered psychotherapy addresses these issues and has good evidence for efficacy in the treatment of depression in the general population.(50) Its limitations are the potential for lower level of involvement with therapy —Kraepelien et al(38) noted that in the feedback following their internetbased interv…”
BackgroundHedman, E., Ljótsson, B., Kaldo, V., Hesser, H., El Alaoui, S., Kraepelien, M., Andersson, E., Rück, C., Svanborg, C., Andersson, G., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.023 · Cited by 224 · cited 1×
“non-PD patients [40] PD patients were considerably less active in contacting their therapist and completing assignments and also had lower degree of satisfaction with the therapy.”
BackgroundKunik, M. E., Veazey, C., Cully, J. A., Souchek, J., Graham, D. P., Hopko, D., Carter, R., Sharafkhaneh, A., Goepfert, E. J., Wray, N., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001687 · Cited by 214 · cited 1×
“Importantly, CBT has also been shown to be efficacious in the treatment of anxiety and depression in the context of chronic neurological(23) and other physically disabling conditions.(24) In this review paper, we aimed to provide an up-to-date summary of the evidence of psychological therapy efficacy for three of the…”
BackgroundTrial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers
Okai, D., Askey-Jones, S., Samuel, M., O’Sullivan, S. S., Chaudhuri, K. R., Martin, A., Mack, J., Brown, R. G., & David, A. S. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840678 · Cited by 202 · cited 11×
“We searched Ovid and PubMed records using search terms: ‘Cognitive-Behavioural Therapy ’, ‘Behavioural’ or ‘Psychological therapy ’ or ‘CBT’ and ‘Parkinson’s Disease’ or ‘PD’.”
BackgroundInfluentialSelf-citationRios Romenets, S., Creti, L., Fichten, C., Bailes, S., Libman, E., Pelletier, A., & Postuma, R. B. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.03.003 · Cited by 166
Troeung, L., Egan, S. J., & Gasson, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079510 · Cited by 132 · cited 1×
“In the case of depression and anxiety, the efficacy of medication was found to be of moderate effect size but statistically non-significant in a pooled analysis.(12) Other issues with antidepressants include concerns over polypharmacy(13).”
BackgroundCognitive-behavioral therapy for depression in Parkinson's disease: a pilot study
Dobkin, R. D., Allen, L. A., & Menza, M. (2007) · Movement Disorders · doi:10.1002/mds.21455 · Cited by 107
Menza, M., Dobkin, R. D., Marin, H., Mark, M. H., Gara, M., Buyske, S., Bienfait, K., & Dicke, A. (2009) · Movement Disorders · doi:10.1002/mds.22586 · Cited by 106 · cited 1×
“Other issues with antidepressants include concerns over polypharmacy [13]).”
BackgroundTelephone-Based Cognitive–Behavioral Therapy for Depression in Parkinson Disease
Dobkin, R. D., Menza, M., Allen, L. A., Tiu, J., Friedman, J., Bienfait, K. L., Gara, M. A., & Mark, M. H. (2011) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988711422529 · Cited by 88
Troeung, L., Egan, S. J., & Gasson, N. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-19 · Cited by 85 · cited 3×
“29 In some instances, there were further modifications to the CBT protocol to accommodate the executive and somatic features of PD: less written material provided to patients, unlimited breaks during session to allow patients to attend to their needs.(29) CBT were delivered by psychologists as well as in some cases by…”
BackgroundMethodInfluentialVeazey, C., Cook, K. F., Stanley, M., Lai, E. C., & Kunik, M. E. (2009) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-009-9167-6 · Cited by 75 · cited 4×
“intervention end [30, 37] and 4 week follow-up [30] but there was no beneficial effect on quality of life.”
BackgroundMethodInfluentialKnott, S., Woodward, D., Hoefkens, A., & Limbert, C. (2015) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465814000393 · Cited by 57
Cole, K., & Vaughan, F. L. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.03.002 · Cited by 49 · cited 3×
“The two case series (three and five patients) also reported significant improvement for depressive symptoms,(34) 35 particularly for those with more severe depression at baseline.(34)”
BackgroundResultInfluentialFeeney, F., Egan, S., & Gasson, N. (2005) · Clinical Psychologist · doi:10.1080/13284200500048240 · Cited by 43 · cited 4×
“Feeney et al (2005)32 4 PD Primary outcomes: BDI and STAI-S Uncontrolled CBT case series Duration: 8 weeks; follow-up: 12 weeks Age 65.3±11 Disease duration 4.8 ±4.9 3 of the 4 patients improved in terms of depression at 1 month follow-up and 2 of 4 at intervention end.”
BackgroundInfluentialA Cognitive-Behavioral Treatment Package for Depression in Parkinson's Disease
Dobkin, R. D., Allen, L. A., & Menza, M. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.3.259 · Cited by 41
Jiménez-Murcia, S., Bove, F. I., Israel, M., Steiger, H., Fernández-Aranda, F., Álvarez-Moya, E., Granero, R., Penelo, E., Vergé, B., Aymamí, M.-N., et al. (2012) · European Addiction Research · doi:10.1159/000337442 · Cited by 32
Kraepelien, M., Svenningsson, P., Lindefors, N., & Kaldo, V. (2015) · Internet Interventions · doi:10.1016/j.invent.2014.11.006 · Cited by 27
Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study
Shinmei, I., Kobayashi, K., Oe, Y., Takagishi, Y., Kanie, A., Ito, M., Takebayashi, Y., Murata, M., Horikoshi, M., & Dobbin, R. D. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s104777 · Cited by 18 · cited 1×
“Therapy duration ranged from 6 to 14 weeks and some studies adapted its content to limitations and problems specific to PD patients.(33) The uncontrolled studies also reported significant improvement in depressive and anxiety at therapy end and follow-up (two studies followed participants at 4 weeks(30) 32 and one at…”
BackgroundDobkin, R. D. (2014) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.13030065 · Cited by 7 · cited 1×
“working memory predicted improvement in depression following the 10 week telephone CBT [39].”
Method
Cited by
Dobkin, R. D., Mann, S. L., Gara, M. A., Interian, A., Rodriguez, K. M., & Menza, M. (2020) · Neurology · doi:10.1212/wnl.0000000000009292 · Cited by 127
Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
Moonen, A. J. H., Mulders, A. E. P., Defebvre, L., Duits, A., Flinois, B., Köhler, S., Kuijf, M. L., Leterme, A., Servant, D., de Vugt, M., et al. (2021) · Movement Disorders · doi:10.1002/mds.28533 · Cited by 71
Zhang, Q., Yang, X., Song, H., & Jin, Y. (2020) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2020.101111 · Cited by 60
Bogosian, A., Hurt, C. S., Hindle, J. V., McCracken, L. M., Vasconcelos e Sa, D. A., Axell, S., Tapper, K., Stevens, J., Hirani, P. S., Salhab, M., et al. (2022) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720988901 · Cited by 55
Lebrun, C., Gély‐Nargeot, M., Rossignol, A., Geny, C., & Bayard, S. (2020) · Journal of Clinical Psychology · doi:10.1002/jclp.22883 · Cited by 32
Metadata
- Authors
- Koychev, I., & Okai, D.
- Venue
- Evidence Based Mental Health
- Publisher
- BMJ
- Published
- 2017-01-10
- Volume
- 20
- Issue
- 1
- Pages
- 15-20
- ISSN
- 1362-0347 (ISSN-L)
- 1468-960X
- OpenAlex
- W2567926359
- Cited by
- 83
- References
- 26
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.